Stockscreener 앱 받기
0.00
100.00%
-4.66
Curevac N V 주식(CVAC)의 최신 뉴스
CureVac Shares Cease Trading Following BioNTech Acquisition - AD HOC NEWS
CureVac Aktie: Strategische Prioritäten - Börse Global
Block Trades: How does SIFY score in quality rankingsInflation Watch & Safe Capital Growth Stock Tips - baoquankhu1.vn
Aug Wrap: Should you avoid CureVac NV stock right nowJuly 2025 Update & Safe Capital Growth Stock Tips - baoquankhu1.vn
Can CureVac N.V. outperform under higher oil pricesJuly 2025 Macro Moves & Scalable Portfolio Growth Methods - mfd.ru
Toyota and Georg Fischer HR veteran to lead BioNTech's global people strategy - Stock Titan
BioNTech Consolidates mRNA Sector with CureVac Acquisition Finalized - AD HOC NEWS
CureVac Concludes Acquisition by BioNTech, Exits Public Markets - AD HOC NEWS
CureVac Shareholders Face Final Tax Reclaim Deadline () - aktiencheck.de
CureVac's Public Market Journey Concludes Following BioNTech Acquisition () - aktiencheck.de
CureVac Exits Public Markets Following BioNTech Acquisition - AD HOC NEWS
BioNTech Completes CureVac Acquisition and Delisting - AD HOC NEWS
CureVac N.V. (CVAC) Investor Outlook: Navigating the Biotechnology Terrain Amidst Strategic Acquisitions - DirectorsTalk Interviews
Earnings Recap: How does XNET score in quality rankingsEarnings Recap Summary & AI Enhanced Trading Signals - baoquankhu1.vn
CureVac (NasdaqGM:CVAC) Valuation After New mRNA Pipeline Progress And Refined Capital Allocation Plan - Yahoo Finance
CureVac Shares Cease Trading Following BioNTech Acquisition Finalization - AD HOC NEWS
CureVac Shares Cease Trading as BioNTech Acquisition Finalizes - AD HOC NEWS
BioNTech’s CureVac Deal Put A Floor Under A Volatile Stock - Finimize
How CureVac N.V. stock reacts to Fed rate cuts2025 Performance Recap & Consistent Growth Equity Picks - Bộ Nội Vụ
Seven big cancer studies BioNTech will report on in 2026 - Stock Titan
CureVac N.V. (NASDAQ:CVAC) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
CureVac’s Market Exit: A New Chapter Begins Under BioNTech - AD HOC NEWS
CureVac’s Stock Market Exit Finalized Following BioNTech Acquisition - AD HOC NEWS
BioNTech Finalizes CureVac Acquisition: A Strategic Consolidation Met with Market Skepticism - The Chronicle-Journal
How CureVac N.V. stock responds to policy changesEarnings Overview Report & Daily Stock Trend Watchlist - Улправда
Does CureVac’s (CVAC) NASDAQ Exit Quietly Recast Its Risk Profile and Equity Story? - simplywall.st
Update Recap: Why CureVac N.V. stock remains on buy listsDip Buying & AI Enhanced Market Trend Forecasts - Улправда
Why CureVac N.V. stock remains on buy listsTrade Risk Report & Long-Term Investment Growth Plans - Улправда
Weekly Trades: What sentiment indicators say about CureVac N.V. stockQuarterly Portfolio Review & Daily Volume Surge Signals - Улправда
How CureVac N.V. stock performs after earningsJuly 2025 Selloffs & Real-Time Stock Price Movement Reports - Улправда
CureVac’s Final Trading Day: A Chapter Closes in the mRNA Sector - AD HOC NEWS
CureVac completes BioNTech-driven reorganization and moves to delist from Nasdaq - MSN
CureVac Shareholders Face Final Chapter as BioNTech Merger Closes () - aktiencheck.de
BioNTech completes CureVac takeover and updates articles of association - MSN
CureVac shares to be delisted from Nasdaq following BioNTech acquisition By Investing.com - Investing.com Nigeria
CureVac’s Stock Market Exit Marks End of an Era for mRNA Pioneer - AD HOC NEWS
CureVac Completes BioNTech-Driven Reorganization and Moves to Delist from Nasdaq - TipRanks
BioNTech Completes CureVac Takeover and Updates Articles of Association - TipRanks
CureVac shares to be delisted from Nasdaq following BioNTech acquisition - Investing.com
CureVac Shareholders Approve BioNTech Exchange Offer - MSN
CureVac's Public Market Journey Concludes with BioNTech Merger Finalization () - aktiencheck.de
CureVac NV’s CVAC Stock: Volatile Gene?Therapy Bet Faces Tough Crowd On Wall Street - AD HOC NEWS
BioNTech’s Strategic Pivot Validated by Recent Developments - AD HOC NEWS
CureVac (NASDAQ:CVAC) Reaches New 12-Month HighWhat's Next? - MarketBeat
BioNTech Consolidates mRNA Leadership with CureVac Acquisition Finalization - AD HOC NEWS
Fundamentals Check: so 6 y nghia la giInsider Buying & Low Risk High Win Rate Stock Picks - moha.gov.vn
A New Chapter Begins: BioNTech Completes CureVac Acquisition - AD HOC NEWS
BioNTech Consolidates mRNA Leadership with CureVac Acquisition Finalized - AD HOC NEWS
BioNTech SE (BNTX) Closes the Acquisition of CureVac N.V. - Finviz
CureVac’s Final Chapter: BioNTech Acquisition Paves Way for Delisting - AD HOC NEWS
1.27%
자본화:
|
볼륨(24시간):